Official HHS guidance for plans and consumers
The Department of Health and Human Services (HHS) released several guidance documents to explain the situations that would allow an extension for consumers beyond the open-enrollment deadline. Based on the morning meltdown of healthcare.gov on deadline day, the extensions might be more than HHS bargained for.
Guidance for Issuers on People “In Line”:http://www.cms.gov/CCIIO/Resources/Regulations-and-Guidance/Downloads/in-line-SEP-3-26-2014.pdf
Guidance for Issuers on Complex Cases:http://www.cms.gov/CCIIO/Resources/Regulations-and-Guidance/Downloads/complex-cases-SEP-3-26-2014.pdf
Assister Tips for those “In Line”: http://marketplace.cms.gov/help-us/assisting-consumers-march-31.pdf
Assister Tips Complex Cases: http://marketplace.cms.gov/help-us/complex-cases-sep.pdf
The consumer fact sheet is posted here: http://marketplace.cms.gov/getofficialresources/publications-and-articles/sep-complex-cases.pdf
IRS guidance for those who are exempt from obtaining coverage:
http://www.irs.gov/uac/ACA-Individual-Shared-Responsibility-Provision-Exemptions
Dupixent Is Linked to a Higher Risk of Psoriasis in Patients With Atopic Dermatitis
July 8th 2025AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and psoriasis driven by Th17 inflammation. However, newer research has shown that these diseases can overlap in patients and may even share common pathways.
Read More
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Autoimmune Diseases Almost Double Mental Health Disorder Risk
July 7th 2025The prevalence of autoimmune disease patients with a mental health disorder is almost twice the number of patients without, suggesting there is a link between inflammation and conditions such as depression, anxiety disorder and bipolar disorder.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen